Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva shares surge after announcing global opioid settlement
New York could get $524M under opioid settlements with Teva - ABC News
Teva, Allergan settle roles in opioid crisis for $4.25B, $2.37B respectively - Top Class Actions
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Three-Stock Lunch: AMD, HAS & TEVA
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
In The News: Teva, Superfeet, Red Wing - Footwear Insight
Teva settles with Oklahoma for $85 million in opioid case | PBS News Weekend
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Teva Pharmaceuticals - Lixoft
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva sees return to growth after opioid settlement, shares jump | Reuters
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
